Iovance Biotherapeutics News - IOVA

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Iovance Biotherapeutics Inc IOVA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.15 -0.6% 24.72 25.00 24.40 24.96 24.87 20:00:00
more quote information »

Recent News

Date Time Source Heading
12/02/201907:00GLOBEIovance Biotherapeutics to Present at Upcoming Investor..
11/21/201907:00GLOBEIovance Biotherapeutics Announces Results of a Subgroup..
11/08/201913:20EDGARConfidential Treatment Order (ct Order)
11/08/201907:00GLOBEIovance Biotherapeutics Announces Updated Phase 2 Clinical..
11/07/201916:32GLOBEIovance Biotherapeutics to Present at Upcoming Investor..
11/04/201917:03EDGARQuarterly Report (10-q)
11/04/201916:13EDGARCurrent Report Filing (8-k)
11/04/201916:01GLOBEIovance Biotherapeutics Reports Third Quarter and September..
10/31/201916:43GLOBEIovance Biotherapeutics to Host Third Quarter 2019 Financial..
10/02/201907:00GLOBEIovance Biotherapeutics Announces Four Abstracts to be..
9/27/201916:30GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
9/25/201906:00EDGARNotice of Effectiveness (effect)
9/17/201916:12EDGARSecurities Registration Statement (simplified Form) (s-3/a)
8/30/201917:03EDGARSecurities Registration Statement (simplified Form) (s-3)
8/26/201916:30GLOBEIovance Biotherapeutics to Present at Upcoming Investor..
8/01/201917:03EDGARQuarterly Report (10-q)
8/01/201916:07EDGARCurrent Report Filing (8-k)
8/01/201916:01GLOBEIovance Biotherapeutics Reports Second Quarter 2019..
7/26/201907:00GLOBEIovance Biotherapeutics to Host Second Quarter 2019..
7/19/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
7/19/201917:15EDGARInitial Statement of Beneficial Ownership (3)
7/18/201908:00GLOBEIovance Biotherapeutics Appoints Friedrich Graf..
7/02/201908:01EDGARCurrent Report Filing (8-k)
7/02/201907:30GLOBEIovance Biotherapeutics Provides Cervical Cancer Program..
6/21/201916:46EDGARCurrent Report Filing (8-k)
6/11/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201917:16EDGARInitial Statement of Beneficial Ownership (3)
6/11/201908:00EDGARCurrent Report Filing (8-k)
6/11/201907:00GLOBEIovance Biotherapeutics Appoints Athena Countouriotis, M.D.,..
6/03/201916:33EDGARCurrent Report Filing (8-k)
5/31/201907:00GLOBEUpdated Results of Studies in Advanced Cervical Cancer and..
5/31/201906:59GLOBEIovance Biotherapeutics to Participate in Upcoming..
5/29/201908:00GLOBEIovance Biotherapeutics Announces New Facility to Support..
5/22/201916:41EDGARCurrent Report Filing (8-k)
5/22/201916:30GLOBEIovance Biotherapeutics Announces Breakthrough Therapy..
5/16/201917:22EDGARCurrent Report Filing (8-k)
5/15/201917:27GLOBEIovance Biotherapeutics Announces Updates to Tumor..
5/07/201917:03EDGARQuarterly Report (10-q)
5/07/201916:09EDGARCurrent Report Filing (8-k)
5/07/201916:01GLOBEIovance Biotherapeutics Reports First Quarter 2019 Financial..
5/02/201907:00GLOBEIovance Biotherapeutics to Participate in Upcoming..
5/01/201917:17EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/01/201907:00GLOBEIovance Biotherapeutics to Host First Quarter 2019 Financial..
4/29/201917:02EDGARProxy Statement (definitive) (def 14a)
4/19/201916:32EDGARProxy Statement - Notice of Shareholders Meeting..
4/03/201907:05GLOBEIovance Biotherapeutics to Present New Data from Ongoing..
4/03/201907:00GLOBEIovance Biotherapeutics Announces Clinical Programs Update
4/02/201907:00GLOBEIovance Biotherapeutics Announces First Patient Dosed in..
See more news about this stock »


Your Recent History
NASDAQ
IOVA
Iovance Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.